Clinical Trial Update On Therapeutic Effects Of
Combined Treatment With Ribavirin And Tiazofurin

post from ** Stu's Views & M.S. News ** on 03 July 2009 07:32:00 AM. © ** Stu's Views & M.S. News **

2 - Jul- 2009
Hard To Treat Diseases (HTDS) Chief Scientist with its Slavica BioChem subsidiary, Dr. Sanja Pekovic provided updates on recent clinical trials with animal subjects in regards to the use of Ribavirin And Tiazofurin for the potential treatment of Multiple Sclerosis (MS).

Dr. Pekovic reported; "It is now well accepted that axonal injury begins at an early stage in MS, and likely accounts for clinical progression seen later in the disease course, suggesting that early, aggressive treatment is critical in order to suppress long-term disability progression. Researchers from IBISS group (a related research group) tested the effect of combined treatment with ribavirin (R) and tiazofurin (T) administrated during the effecter phase of disease.

Read More
====================

Keep Current with MS information by registering at our website http://www.msviewsandnews.org - After registering you will begin receiving the weekly MS e-Newsletter called "Stu's Views and MS Related News".This weekly publication is being received in (48) countries.If not yet receiving this, join now, to not miss another issue. - thank you

Read The Full Article:
http://wwwmsviewsandrelatednews.blogspot.com/2009/07/clinical-trial-update-on-the
rapeutic.html